Dr. Gevorg Tamamyan, WHO Director-General candidate, Professor and Chairman of the Department of Pediatric Oncology and Hematology at Yerevan State Medical University and Editor-in-Chief of OncoDaily, was recently honored with the Emirates Oncology Society (EOS) Special Recognition Award at its 7th Annual Conference, held on 3 – 4 October 2026 at the InterContinental Dubai Festival City, UAE, and shared his words of appreciation to EOS for the recognition:
“It is such an honor to receive the EOS Special Recognition Award from the Emirates Oncology Society. Thank you so much for this honor, dear Prof. Humaid Al-Shamsi, and sorry I was not able to be there in person, but our team was there and they were greatly impressed with an outstanding congress and hospitality.
Thanks a lot again, my friend.”
About Dr. Gevorg Tamamyan
Dr Gevorg Tamamyan, MD, MSc, PhD, DSc, FASCO, is a prospective candidate for the post of Director-General of the World Health Organization, nominated by the Republic of Botswana. He is a global leader in oncology, health systems strengthening, and international health cooperation, recognized for building bridges between countries and advancing equitable cancer care in resource-limited settings.
Dr. Tamamyan is Professor and Chairman of the Department of Pediatric Oncology and Hematology at Yerevan State Medical University and CEO of the Immune Oncology Research Institute (IMMONC).
He is the Co-Founder and Editor-in-Chief of OncoDaily, one of the world’s largest oncology media platforms, created to democratize access to reliable, independent, and evidence-based cancer information globally.
Dr. Tamamyan was elected and currently serves as President of two major international pediatric oncology organizations: the International Society of Pediatric Oncology (SIOP) Asia Continental Branch, representing pediatric oncology professionals across Asia, and the Pediatric Oncology East and Mediterranean (POEM) Group, uniting 28 countries and 110 cancer centers. He also serves as Co-Chair of the St. Jude EURO Regional Advisory Committee, encompassing 13 European countries.
At the age of 32, Dr. Tamamyan was appointed Head of the Pediatric Cancer and Blood Disorders Center of Armenia, where he led the consolidation of previously fragmented pediatric oncology and hematology services into a single national center. Under his leadership, the Center evolved into a regional reference point, with survival rates reaching up to 80%.
He also co-founded City of Smile, a national pediatric cancer charity that helps ensure universal coverage for the diagnosis and treatment of every child and young adult with cancer in Armenia.
Dr. Tamamyan is Chairman of the Board of the Institute of Cancer and Crisis and an adviser to the Rector of Yerevan State Medical University. He previously served as President of the Harvard Club of Armenia.
Educated and trained across seven countries in Europe, North America, and Asia, his professional journey spans frontline clinical practice, research, academic leadership, national cancer center management, global health diplomacy, and institution building.
He is the recipient of numerous international awards and distinctions, including Fellow of the American Society of Clinical Oncology (FASCO); ASCO LIFe and IDEA Awards; UICC and IARC Young Leader Awards; the 40 Under 40 in Cancer Award; the Latin American and Caribbean Society of Medical Oncology (SLACOM) Award for Global Oncology Leadership; and the Global Health Catalyst Distinguished Leader Award.
He is married and has two daughters, Charlize and Letizia.
Dr Gevorg Tamamyan is Nominated as a Candidate for WHO Director-General Position
About Emirates Oncology Society – EOS
The Emirates Oncology Society is dedicated to promoting and fostering the multidimensional care of cancer patients throughout the United Arab Emirates, by bringing together all of the practising cancer specialists across all disciplines.
Since its establishment, EOS has helped strengthen region-specific oncology research and clinical practice. Among its major achievements are the publication of Cancer in the Arab World and Cancer Care in the United Arab Emirates with Springer Nature, providing comprehensive resources on cancer epidemiology, healthcare infrastructure, and the unique challenges of cancer care across the region.
EOS also developed the world’s first international clinical recommendations for the management of cancer patients during COVID-19, contributing to the global response to the pandemic.
Today, the society works with national health authorities to support quality standards in oncology and brings leading international knowledge to regional clinicians through initiatives including the Emirates Oncology Conference, ASCO Direct, Best of ESMO, and Best of SABCS. Through these efforts, EOS continues to advance high-quality, evidence-based cancer care in the UAE and across the region.